JP Morgan analyst Domingos Falavina upgrades Cielo (OTC:CIOXY) from Underweight to Neutral.
Benchmark Maintains Buy on Amedisys, Lowers Price Target to $120
Benchmark analyst Bill Sutherland maintains Amedisys (NASDAQ:AMED) with a Buy and lowers the price target from $135 to $120.